|本期目录/Table of Contents|

[1]魏春苗,夏桂枝,任榕娜.伴强直发作的Dravet综合征2例报告并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):152-155.[doi:10.3969/j.issn.1672-271X.2018.02.010]
 WEI Chun-miao,XIA Gui-zhi,REN Rong-na.Dravet syndrome with tonic seizure: 2 cases report and literature review[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):152-155.[doi:10.3969/j.issn.1672-271X.2018.02.010]
点击复制

伴强直发作的Dravet综合征2例报告并文献复习()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第20卷
期数:
2018年02期
页码:
152-155
栏目:
出版日期:
2018-03-20

文章信息/Info

Title:
Dravet syndrome with tonic seizure: 2 cases report and literature review
作者:
魏春苗夏桂枝任榕娜
作者单位:350025 福州,蚌埠医学院福总教学医院儿科(魏春苗);350025 福州,福建医科大学福总临床医学院儿科(夏桂枝);350025 福州,南京军区福州总医院儿科(任榕娜)
Author(s):
WEI Chun-miao1 XIA Gui-zhi2 REN Rong-na3
(1.Department of Paediatic,Fuzhou General Hospital Clinical Medical College of Bengbu Medical University, Fuzhou 350025,Fujian,China;2. Department of Paediatic,Fuzhou General Hospital Clinical Medical College of Fujian Medical University, Fuzhou 350025, F
关键词:
Dravet综合征强直发作SCN1A基因新发突变
Keywords:
Dravet syndrome tonic seizure SCN1A gene de novo mutation
分类号:
R725
DOI:
10.3969/j.issn.1672-271X.2018.02.010
文献标志码:
A
摘要:
目的 分析伴强直发作的Dravet综合征的临床及基因突变特点,以期对Dravet综合征少见表型早期诊断及合理治疗。方法 对2011年1月至2017年3月在福州总医院儿科神经专科门诊及病房诊治的2例伴强直发作的Dravet综合征的临床和基因突变特点进行回顾性分析,结合相关文献进行总结。结果 2例患儿分别在出生5个月和8个月时以热性惊厥起病,病程中除有全身及偏侧阵挛、强直阵挛和不典型失神等多种Dravet综合征常见的发作形式外,均出现了Dravet综合征少见的强直发作,2例患儿均对多种抗癫痫药物疗效不佳,现均有不同程度的精神运动发育落后,2例基因检测均为SCN1A基因新发错义突变。结论 Dravet综合征可出现少见的强直发作形式,基因检测有助于这种Dravet综合征少见表型的早期诊断及合理治疗。
Abstract:
Objective To achieve early diagnosis and correct treatment to the rare phenotype of Dravet syndrome to analyze the clinical features and genetic mutation of Dravet syndrome with tonic seizure.Methods The clinical information was collected from Fuzhou General Hospital between January 2011 to March 2017. The related literature were reviewed. Results Febrile seizures onset in the 5th month and the 8th month after birth for 2 cases. Except for general clonic, hemiclonic, general tonic-clonic, myoclonus and atypical absence seizure, tonic seizure was also observed in the course of the disease and the children represented slowing of psychomotor development. De novo missense mutation of SCN1A gene was found by Genetic screening for 2 cases.Conclusion Tonic seizure can be observed on the Dravet syndrome. Genetic screening is helpful to early diagnosis and correct treatment for this rare phenotype.

参考文献/References:

[1]Wu YW, Sullivan J, McDaniel SS, et al. Incidence of Dravet syndrome in a US population[J]. Pediatrics, 2015, 136(5): 1310-1315.
[2]Bayat A, Hjalgrim H, Moller RS, et al. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22000: a population-based study from 2004 to 2009[J]. Epilepsia, 2015, 56(4): 36-39.
[3]Shmuely S, Sisodiya SM, Gunning WB, et al. Mortality in Dravet syndrome: a review[J]. Epilepsy Behav, 2016, 64(Pt A): 69-74.
[4]黄逸青,吴原.癫痫猝死模型的研究进展[J].医学研究生学报,2016,29(1):100-103.
[5]Dravet C. Dravet syndrome history[J]. Dev Med Child Neurol, 2011, 53( Suppl 2):1-6.
[6]Scheffer IE. Diagnosis and long-term course of Dravet syndrome[J]. Eur J Paediatr Neurol, 2012, 16( Suppl 1): S5- S8
[7]Dravet C. Les e′pilepsies graves de l′enfant[J]. Vie Med,1978, 8:543-548.
[8]Dravet C. The core Dravet syndrome phenotype[J]. Epilepsia, 2011, 52(Suppl 2):3-9.
[9]Nabbout R, Desguerre I, Sabbagh S, et al. An unexpected EEG course in Dravet syndrome[J]. Epilepsy Res, 2008, 81(1):90-95.
[10]Connolly MB. Dravet syndrome: Diagnosis and long-term course[J]. Can J Neurol Sci, 2016, 43 (Suppl 3): S3-S8.
[11]Gataullina S, Dulac O. From genotype to phenotype in Dravet disease[J]. Seizure, 2017,44:58-64.
[12]Claes L, Del-favero J, ceulemans B, et al. De nove mutation in the sodium channel gene SCN1A cause severe myoclonic epileptic in fancy[J]. Am J Hum genet, 2001, 68(6):1327-1332.
[13]许小菁, 张月华, 孙慧慧, 等. Dravet综合征SCN1A基因突变的遗传特点及表型研究[J].中华医学遗传学杂志, 2012, 29(6): 625-630.
[14]Depienne C, Trouillard O, Saint-Martin C, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients[J]. Med Genet, 2009, 46(3): 183-191.
[15]Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females[J]. PLoS Genet, 2009, 5(2):e1000381.
[16]Patino GA, Claes LR, Lopez-Santiago LF, et al. functional null mutation of SCN1B in a patient with Dravet syndrome[J]. J Neurosci, 2009, 29(34):10764-10778.
[17]Carvill GL, Weckhuysen S, McMahon JM, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome[J]. Neurology, 2014, 82(14):1245-1253.
[18]Cheah CS, Yu FH, Westenbroek RE, et al. Specific deletion of NaV1.1 sodium channels ininhibitory interneurons causes seizures and premature death in amouse model of Dravet syndrome[J]. Proc Natl Acad Sci USA, 2012, 109(36):14646-14651.
[19]Grosenbaugh DK, Mott DD. Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus[J]. Neuropharmacology, 2013, 67:136-143.
[20]Wirrell EC. Treatment of Dravet syndrome[J]. Can J Neurol Sci,2016, 43 (Suppl 3): S13-S18.
[21]Aras LM, Isla J, Mingorance-Le Meur A. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome[J].Epilepsy Behav, 2015, 44:104-109.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2018-03-20